RecruitingNot ApplicableNCT06291922

Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation

Sponsor

University of Pennsylvania

Enrollment

100 participants

Start Date

Aug 14, 2024

Study Type

INTERVENTIONAL

Conditions

Heart Failure

Summary

The goal of this clinical trial is to evaluate the effects of a home-based exercise program using mobile technology on physical activity and capacity, frailty and muscle mass, and quality of life in patients with a newly implanted HeartMate 3 left ventricular assist device (HM3 LVAD). Researchers will compare the effects of an exercise intervention vs. usual care on physical activity and capacity, frailty and muscle mass, and quality of life.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

≥ 18 years of age
Newly implanted with a HeartMate 3™ LVAD for the first time
Able to ambulate independently (with or without the use of an assistive device)
Owns a smartphone with Internet connection
Patient will be discharged home with LVAD or patient will be living at home with LVAD within 45 days of index discharge

Exclusion Criteria1

\. Major comorbidities or limitations that may interfere with exercise training (including significant orthopedic/neurologic limitations, decompensated heart failure, uncontrolled arrhythmias, unstable angina)